Advertisement
The Cardiovascular Aging Research & Development (CARD) Symposium brings together leaders across biotechnology, medicine, and academia to discuss the next generation of cardiovascular therapeutics: from emerging clinical trials and precision cardiology to the molecular mechanisms driving cardiometabolic disease.We're excited to announce our featured speakers:
John Maraganore, PhD (Founding CEO of Alnylam; Co-CEO of Corsera Health)
Sekar Kathiresan, MD (CEO of Verve Therapeutics; SVP at Eli Lilly)
Michelle O'Donoghue, MD (Senior Investigator, TIMI Study Group; Associate Professor of Medicine at Harvard Medical School)
Roxana Mehran, MD (President of American College of Cardiology; Mount Sinai Endowed Professor of Medicine at the Icahn School of Medicine)
Michael Davidson, MD (CEO of NewAmsterdam Pharma)
Lada Nuzhna (CEO of General Control)
Martin Borch Jensen, PhD (Co-founder and CEO of Gordian Biotechnology)
Scientific sessions will explore topics ranging from AI-driven cardiovascular data analysis and precision medicine to Lp(a)-targeted therapeutics, gene editing, cardiometabolic drug development, lipid biology, aldosterone dysregulation, vascular inflammation, and the translation of basic discoveries into new clinical therapies.
Hosted by the Aging Initiative, CARD aims to bridge basic science, translational research, clinical medicine, and biotechnology to accelerate progress against cardiovascular disease, the world's leading cause of death.
Thursday, May 6, 2027 | 3:00–7:00 PMMuseum of Science, Boston
Registration approval is required to attend.
Interested in sponsoring the symposium?Contact [email protected].
Advertisement
Event venue
Boston, United States
Tickets
USD 0
Discover more events by tag
Conferences in BostonMedical in BostonArtificial-intelligence in BostonEntrepreneurship in BostonBusiness in BostonTechnology in Boston